Trial Profile

A Phase IIa Clinical Trial of a Single-Center, Randomized, Blinded, Controlled Study with Comparing Similar Vaccines for Evaluating the Immunogenicity and Safety of VZV-7D

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 19 Aug 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Live attenuated varicella vaccine-Beijing Wantai Biopharmaceutical (Primary)
Indications Varicella zoster virus infections
Focus Adverse reactions; Pharmacodynamics
Sponsors Beijing Wantai Bio-pharm

Most Recent Events

01 Aug 2024 Results assessing the immunogenicity and safety of a skin-attenuated and neuro-attenuated varicella vaccine candidate (v7D vaccine) presented in The Lancet Infectious Diseases
03 Aug 2020 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com